Innovative ETFs Content Hub A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark By Max ChenJune 30, 2021
Innovative ETFs Content Hub The Biotech Trek: A Short History from 1993 to 2021 By Max ChenJune 29, 2021
Innovative ETFs Content Hub Healthcare Services ETFs Could Continue to Rally By Max ChenJune 24, 2021
Modern Alpha Content Hub The BioRevolution: An ETF That Taps Into Nearly Everything By Max ChenJune 21, 2021
Equity ETF Content Hub Play the Technology Side of Healthcare with the IHI ETF By Ben HernandezApril 13, 2021
Leveraged & Inverse Content Hub Biden’s Infrastructure Can Put These 2 Leveraged Funds in Play By Ben HernandezApril 9, 2021
Innovative ETFs Content Hub Greater Regulatory Scrutiny Could Weigh on Biotech ETFs By Max ChenMarch 24, 2021
Thematic Investing Content Hub Healthcare. China. This Global X ETF Combines Two Potent Sectors By Ben HernandezMarch 3, 2021
Innovative ETFs Content Hub Illumina Earnings, Forward Guidance Strengthen Biotech ETFs By Max ChenFebruary 12, 2021
Innovative ETFs Content Hub Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug By Max ChenJanuary 29, 2021
Innovative ETFs Content Hub Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Innovative ETFs Content Hub Biotech ETFs Tracking CRISPR Gene Editing Surge By Max ChenDecember 21, 2020
